Core Viewpoint - A shareholder has filed a securities class action lawsuit against Driven Brands Holdings Inc. for alleged misrepresentations regarding the company's financial condition during the class period from May 9, 2023, to February 24, 2026 [1][4]. Group 1: Lawsuit Details - The lawsuit represents investors who purchased or acquired common stock of Driven Brands during the specified class period [1]. - Defendants are accused of making false statements about the company's financial health throughout the class period [4]. Group 2: Legal Process - Investors wishing to serve as lead plaintiff must file necessary documents by May 8, 2026 [3]. - Participation as a lead plaintiff is not required to share in any potential recovery from the lawsuit [3]. Group 3: Firm Background - Bernstein Liebhard LLP, the law firm handling the case, has recovered over $3.5 billion for clients since its inception in 1993 [5]. - The firm has a strong reputation, being named to The National Law Journal's "Plaintiffs' Hot List" thirteen times and recognized in The Legal 500 for sixteen consecutive years [5].

New York, New York--(Newsfile Corp. - March 19, 2026) - Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the "Class") who purchased or acquired the common stock of Boston Scientific Corporation ("Boston Scientific" or the "Company") (NYSE: BSX) between July 23, 2025 and February 3, 2026, inclusive.Should You Join The Boston Scientific Class Action Lawsuit?Do you, or did you, own shares of Boston Scientific Corporation (NYSE: BSX)?Did yo ...

Core Viewpoint - The Gartner class action lawsuit alleges that Gartner, Inc. and certain executives made misleading statements regarding the company's contract value growth and consulting segment revenue, leading to significant stock price declines [4][5][6]. Group 1: Allegations and Financial Impact - The lawsuit claims that Gartner created a false impression of reliable information regarding its contract value growth potential and consulting revenue outlook while downplaying risks from seasonality and macroeconomic factors [4]. - On August 5, 2025, Gartner reported a decline in overall contract value growth from 7% to 5% and ex-federal contract value growth from 8% to 6%, resulting in a stock price drop of over 27% [5]. - On February 3, 2026, Gartner announced a further decline in contract value growth by an additional 2%, including and excluding federal contracts, and revealed a significant shortfall in its consulting segment performance, causing the stock price to fall nearly 21% [6]. Group 2: Class Action Process - The Private Securities Litigation Reform Act of 1995 allows any investor who purchased Gartner common stock during the class period to seek appointment as lead plaintiff in the class action lawsuit [7]. - The lead plaintiff is typically the investor with the greatest financial interest in the case and acts on behalf of all other class members [7]. Group 3: Law Firm Background - Robbins Geller Rudman & Dowd LLP is a leading law firm specializing in securities fraud and shareholder rights litigation, having recovered over $916 million for investors in 2025 alone [8]. - The firm has a strong track record, recovering $8.4 billion for investors over the past five years, including the largest securities class action recovery in history at $7.2 billion [8].

ODD Investor Alert: ODDITY Tech Ltd. Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Allegedly Misleading Institutional Shareholders: SueWallSt Accessibility StatementSkip NavigationNotice to Pension Funds, Asset Managers, and FiduciariesNEW YORK, March 19, 2026 /PRNewswire/ -- Institutional investors holding positions in ODDITY Tech Ltd. (NASDAQ: ODD) during the period February 26, 2025 through February 24, 2026 may wish to evaluate lead plaintiff opportunities in a ...

Core Viewpoint - A class action lawsuit has been filed against ChowChow Cloud International Holdings Limited (CHOW) for allegedly concealing manipulation risks during its IPO, leading to significant losses for investors [1][2]. Group 1: Lawsuit Details - The class action is on behalf of investors who purchased CHOW securities between September 16, 2025, and December 10, 2025, following a dramatic 84.3% collapse in share price from $11.70 to $1.83 on December 10, 2025 [1][2]. - Investors who bought shares at or above the $4.00 IPO price incurred losses of up to $9.87 per share [2]. - The lawsuit claims that CHOW's Registration Statement and Prospectus contained materially misleading statements and omissions, misrepresenting the company as a legitimate cloud solutions provider while concealing its involvement in a pump-and-dump scheme [2][5]. Group 2: Underwriter's Role and Allegations - The Underwriting Agreement allowed US Tiger Securities to review the Registration Statement and Prospectus, which is linked to a history of involvement in microcap IPOs that faced severe price declines and trading halts [3][5]. - US Tiger Securities had previously been fined by FINRA for anti-money laundering compliance failures, a fact not disclosed in the Prospectus [5]. - The low-float IPO structure of 2.6 million shares allegedly facilitated price manipulation, as even minor coordinated buying could lead to significant price fluctuations [5]. Group 3: Misrepresentation and Risk Disclosures - The Prospectus described CHOW as a "pioneer in providing one-stop cloud solutions" without disclosing the company's alleged involvement in a market manipulation scheme [5]. - Risk disclosures in the Prospectus addressed generic volatility but failed to mention specific risks related to fraudulent activities inflating the stock price through social media impersonation [5].

SUEWALLST, LLP: LAKELAND'S $46M OFFERING ALLEGEDLY CONCEALED ACQUISITION RISKS Accessibility StatementSkip NavigationShareholders Who Acquired Shares in the January 2025 Offering Urged to Review OptionsNEW YORK, March 19, 2026 /PRNewswire/ -- SueWallSt announces that a securities class action has been filed against Lakeland Industries, Inc. (NASDAQ: LAKE).YOU MAY BE AFFECTED IF YOU:Acquired shares in or traceable to the Company's January 2025 public offeringLost money on your Lakeland Industries investmentP ...

Core Viewpoint - A securities class action has been filed against Driven Brands Holdings Inc. due to alleged concealment of significant accounting errors that led to a nearly 40% drop in share price after the company disclosed material errors in its financial statements [1][2]. Financial Discrepancies - Driven Brands' shares fell by $6.62 per share, representing a nearly 40% decline, following the announcement of material errors in financial statements spanning nearly three years [2]. - The lawsuit alleges that an unreconciled cash balance from fiscal year 2023 contributed to overstated revenue and cash, as well as understated operating expenses across fiscal years 2023 and 2024 [3][7]. Misleading Financial Reporting - The company reportedly presented misleading revenue growth narratives in its SEC filings, claiming increases of 20%, 19%, and 12%, while the actual figures were based on unreconciled accounts and misclassified entries [4]. - The complaint outlines ten categories of financial statement errors, including improper revenue recognition and misclassification of expenses, which obscured the true cost structure [5][7]. Internal Control Failures - As of November 5, 2025, the company's Q3 2025 10-Q stated that its disclosure controls were effective, but less than four months later, it admitted those controls were ineffective and material weaknesses existed in financial reporting [5]. - PricewaterhouseCoopers LLP concluded that the company's financial statements and internal controls should not be relied upon, raising questions about the timing of risk disclosures to investors [8].

Core Viewpoint - GrafTech International, Ltd. is facing a potential class action lawsuit due to significant stock price decline attributed to disappointing financial results and negative market outlook [1][3][4]. Financial Performance - GrafTech's stock price dropped by $7.25 per share, or 46.21%, closing at $8.44 per share on February 6, 2026, following the release of its fourth quarter and full year 2025 financial results [3]. - The company reported an adjusted loss per share of $2.45, which was significantly worse than consensus estimates, indicating severe fiscal distress [3]. Market Outlook - The CEO of GrafTech described the current market as a "challenging environment," highlighting intensified competitive pricing pressures for graphite electrodes [4]. - The company warned that the current pricing dynamics are unsustainable for both the graphite electrode industry and the long-term health of the steel industry, leading to a loss of investor confidence [4].

Core Viewpoint - Nektar Therapeutics is facing a securities class action lawsuit due to alleged misrepresentations regarding patient enrollment compliance in its pivotal REZOLVE-AA clinical trial, which has raised concerns about the integrity of the trial results [1][4][6]. Group 1: Lawsuit Details - The class action seeks to recover damages for investors who purchased Nektar securities between February 26, 2025, and December 15, 2025 [2]. - Nektar's shares fell by $4.14, or 7.77%, closing at $49.16 on December 16, 2025, following the disclosure of enrollment violations in the REZOLVE-AA trial [3]. - Investors have until May 5, 2026, to seek lead plaintiff status in the lawsuit [3]. Group 2: Clinical Trial Enrollment Issues - The REZOLVE-AA trial required strict patient eligibility criteria, including a SALT score between 50 and 100, stable disease for at least six months, and completion of an eight-week washout period from prior medications [3]. - The lawsuit claims that Nektar failed to enforce these standards, resulting in the randomization of four ineligible patients, which constituted over 4% of the total 94 patients randomized [4][5]. - The trial's primary endpoint narrowly missed statistical significance when including the ineligible patients, with p-values of 0.186 and 0.121 for the two dosing arms [5]. Group 3: Management's Misrepresentation - Nektar management allegedly misled investors by claiming adherence to trial protocols while ineligible patients were enrolled [6]. - The complaint highlights a significant gap between Nektar's representations about its enrollment procedures and the actual practices at its trial sites [4]. - Joseph E. Levi, Esq. emphasized that shareholders deserve accurate information regarding the integrity of the clinical enrollment process [7].

CWH Investor Alert: Camping World Holdings, Inc. Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Management Allegedly Concealed Inventory Risks: SueWallSt Accessibility StatementSkip NavigationThe Red Flags: What Insiders Allegedly Knew Before Shareholders DidNEW YORK, March 19, 2026 /PRNewswire/ -- SueWallSt announces that a securities class action has been filed against Camping World Holdings, Inc. (NYSE: CWH).YOU MAY BE AFFECTED IF YOU:Lost money on your Camping W ...